| scholarly article | Q13442814 |
| P50 | author | Victoria Cardona | Q54153242 |
| Moises Labrador-Horrillo | Q55948479 | ||
| María Vicario | Q79149570 | ||
| Teresa Garriga | Q83627263 | ||
| Mar Guilarte | Q42889280 | ||
| P2093 | author name string | Olga Luengo | |
| Anna Sala-Cunill | |||
| Olga Esteso | |||
| P2860 | cites work | Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions | Q45901791 |
| Diagnosis and treatment of insect sensitivity. | Q52474193 | ||
| Further Experiences with Severe Allergic Reactions to Insect Stings | Q52639428 | ||
| Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti | Q52699890 | ||
| Laboratory diagnosis of acute anaphylaxis. | Q52731066 | ||
| Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. | Q54153238 | ||
| Allergy and the cardiovascular system | Q24644929 | ||
| Anaphylaxis: Recent advances in assessment and treatment | Q30227506 | ||
| Emergency department anaphylaxis: A review of 142 patients in a single year | Q33147010 | ||
| Anaphylaxis: mechanisms and management | Q34192100 | ||
| Clinical features and severity grading of anaphylaxis | Q34341881 | ||
| Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study | Q34509561 | ||
| Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents | Q34536521 | ||
| Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis | Q34572252 | ||
| Cardiovascular disease and anaphylaxis | Q34647959 | ||
| Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions | Q36100892 | ||
| Diagnostic value of tryptase in anaphylaxis and mastocytosis | Q36576420 | ||
| Fatal anaphylaxis: postmortem findings and associated comorbid diseases | Q36766696 | ||
| Risk assessment in anaphylaxis: current and future approaches | Q36865818 | ||
| Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy? | Q37123687 | ||
| Discontinuing venom immunotherapy: extended observations | Q41731183 | ||
| Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions | Q43274048 | ||
| Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. | Q44448615 | ||
| Markers of mast cell degranulation | Q45106543 | ||
| P433 | issue | 2 | |
| P921 | main subject | anaphylaxis | Q168800 |
| patient | Q181600 | ||
| anaphylactic shock | Q15965523 | ||
| P304 | page(s) | 192-199 | |
| P577 | publication date | 2012-09-25 | |
| P1433 | published in | International Archives of Allergy and Immunology | Q2189251 |
| P1476 | title | Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients | |
| P478 | volume | 160 |
| Q38803967 | A 17-year experience in perioperative anaphylaxis 1998-2015: harmonizing optimal detection of mast cell mediator release |
| Q38221739 | Anaphylaxis as a clinical manifestation of clonal mast cell disorders. |
| Q38761189 | Anaphylaxis during general anaesthesia: experience from a drug allergy centre in the UK. |
| Q36177207 | Anaphylaxis following atropine administration during general anesthesia: a case report |
| Q34423618 | Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. |
| Q47376781 | Basal serum tryptase is not a risk factor for immediate-type drug hypersensitivity during childhood |
| Q64071705 | Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives |
| Q26798184 | Clinical development methodology for infusion-related reactions with monoclonal antibodies |
| Q38542316 | Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis? |
| Q38222050 | Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators |
| Q31119549 | Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis? |
| Q58565107 | Evaluation of the left venticular systolic function with the measurement of global longitudinal strain by Speckle tracking echocardiography in anaphylaxis |
| Q41072058 | Fatal laryngeal angioedema: a case report and a workup of angioedema in a forensic setting |
| Q89110476 | Food-Induced Anaphylaxis: an Update |
| Q40089636 | Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout |
| Q38850401 | How to interpret mast cell tests |
| Q39909074 | In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper |
| Q33687257 | International consensus on (ICON) anaphylaxis |
| Q93003405 | Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients |
| Q33690086 | Multifactorial Modulation of Food-Induced Anaphylaxis |
| Q38764567 | Patterns of anaphylaxis after diagnostic workup: A follow-up study of 226 patients with suspected anaphylaxis |
| Q88124330 | Perioperative anaphylaxis |
| Q45323769 | Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths. |
| Q39103035 | Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology |
| Q38541188 | Presentation and Diagnosis of Hypersensitivity to Platinum Drugs |
| Q39414918 | Pro and Contra: Provocation Tests in Drug Hypersensitivity |
| Q42449384 | Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. |
| Q38854006 | Serum levels of 9α,11β-PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis. |
| Q48377828 | Serum mast cell tryptase measurements: Sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia. |
| Q50472439 | Splenic hypereosinophilia in anaphylaxis-related death: different assessments depending on different types of allergens? |
| Q33831572 | The utility of serum tryptase in the diagnosis of food-induced anaphylaxis. |
| Q37695073 | Vaccination and anaphylaxis: a forensic perspective |
| Q34368942 | World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base |
| Q86068843 | [Value of in-vitro diagnostic tools after anaphylaxis] |
Search more.